Bionano reports Q2 revenue, raises guidance
Bionano Genomics said Q2 2026 revenue was $8.2 million, raised FY26 guidance and gave a FY27 revenue target. It also projected EBITDA break-even in Q4 FY27.
Key Highlights:Original SEC Filing: Bionano Genomics, Inc. [ BNGO ] - 8-K - Sep. 14, 2026This is an AI-powered summary. It may contain inaccuracies…